Genome editing technologies: defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 May 2015
|
| In: |
Molecular therapy
Year: 2015, Jahrgang: 23, Heft: 5, Pages: 796-806 |
| ISSN: | 1525-0024 |
| DOI: | 10.1038/mt.2015.54 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/mt.2015.54 Verlag, kostenfrei, Volltext: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427885/ 
|
| Verfasserangaben: | Jacqueline Corrigan-Curay, Marina O'Reilly, Donald B. Kohn, Paula M. Cannon, Gang Bao, Frederic D. Bushman, Dana Carroll, Toni Cathomen, J. Keith Joung, David Roth, Michel Sadelain, Andrew M. Scharenberg, Christof von Kalle, Feng Zhang, Robert Jambou, Eugene Rosenthal, Morad Hassani, Aparna Singh and Matthew H. Porteus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1558781528 | ||
| 003 | DE-627 | ||
| 005 | 20230428071123.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170518s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/mt.2015.54 |2 doi | |
| 035 | |a (DE-627)1558781528 | ||
| 035 | |a (DE-576)488781523 | ||
| 035 | |a (DE-599)BSZ488781523 | ||
| 035 | |a (OCoLC)1340975609 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Corrigan-Curay, Jacqueline |e VerfasserIn |0 (DE-588)1132282640 |0 (DE-627)887701760 |0 (DE-576)48878087X |4 aut | |
| 245 | 1 | 0 | |a Genome editing technologies |b defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014 |c Jacqueline Corrigan-Curay, Marina O'Reilly, Donald B. Kohn, Paula M. Cannon, Gang Bao, Frederic D. Bushman, Dana Carroll, Toni Cathomen, J. Keith Joung, David Roth, Michel Sadelain, Andrew M. Scharenberg, Christof von Kalle, Feng Zhang, Robert Jambou, Eugene Rosenthal, Morad Hassani, Aparna Singh and Matthew H. Porteus |
| 264 | 1 | |c 5 May 2015 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.05.2017 | ||
| 700 | 1 | |a Kalle, Christof von |d 1962- |e VerfasserIn |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy |d Amsterdam : Elsevier, 2000 |g 23(2015), 5, Seite 796-806 |h Online-Ressource |w (DE-627)320415198 |w (DE-600)2001818-6 |w (DE-576)104344695 |x 1525-0024 |7 nnas |a Genome editing technologies defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014 |
| 773 | 1 | 8 | |g volume:23 |g year:2015 |g number:5 |g pages:796-806 |g extent:11 |a Genome editing technologies defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/mt.2015.54 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427885/ |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170518 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1036481115 |a Kalle, Christof von |m 1036481115:Kalle, Christof von |d 910000 |e 910000PK1036481115 |k 0/910000/ |p 13 | ||
| 999 | |a KXP-PPN1558781528 |e 2969695936 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Jacqueline Corrigan-Curay, Marina O'Reilly, Donald B. Kohn, Paula M. Cannon, Gang Bao, Frederic D. Bushman, Dana Carroll, Toni Cathomen, J. Keith Joung, David Roth, Michel Sadelain, Andrew M. Scharenberg, Christof von Kalle, Feng Zhang, Robert Jambou, Eugene Rosenthal, Morad Hassani, Aparna Singh and Matthew H. Porteus"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"5 May 2015"}],"recId":"1558781528","person":[{"role":"aut","family":"Corrigan-Curay","display":"Corrigan-Curay, Jacqueline","given":"Jacqueline"},{"display":"Kalle, Christof von","given":"Christof von","family":"Kalle","role":"aut"}],"title":[{"title":"Genome editing technologies","title_sort":"Genome editing technologies","subtitle":"defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014"}],"language":["eng"],"id":{"eki":["1558781528"],"doi":["10.1038/mt.2015.54"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"11 S."}],"note":["Gesehen am 18.05.2017"],"relHost":[{"language":["eng"],"recId":"320415198","disp":"Genome editing technologies defining a path to clinic : genomic editing : establishing preclinical toxicology standards, Bethesda, Maryland 10 June 2014Molecular therapy","pubHistory":["1.2000 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy","title_sort":"Molecular therapy"}],"origin":[{"dateIssuedKey":"2000","publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla.","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","dateIssuedDisp":"2000-"}],"corporate":[{"role":"isb","display":"American Society of Gene Therapy"}],"note":["Gesehen am 28.05.2020"],"id":{"eki":["320415198"],"zdb":["2001818-6"],"issn":["1525-0024"]},"part":{"year":"2015","pages":"796-806","volume":"23","text":"23(2015), 5, Seite 796-806","extent":"11","issue":"5"},"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a CORRIGANCUGENOMEEDIT5201 | ||